secwatch.observer — SEC 8-K summary
======================================

Issuer:     Carisma Therapeutics Inc. (CARM)
CIK:        0001485003
Form:       8-K
Filed at:   2025-08-08T23:59:59+00:00
Accession:  0001104659-25-075680
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Carisma stockholders approve reverse stock split at ratio of 1:10 to 1:50
-------------------------------------------------------------------------

- Stockholders adopted reverse split amendment; board has sole discretion to set exact ratio (1:10 to 1:50) and timing.
- Vote results: 21,783,014 for, 3,352,989 against, 92,853 abstain.
- Adjournment proposal also approved but was not needed due to quorum and sufficient votes for the reverse split.
- No further stockholder approval is required for implementation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1485003/000110465925075680/0001104659-25-075680-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1485003/000110465925075680/tm2522922d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-075680

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer